Interscalene Brachial Plexus Block and Early Wound-Related Symptoms After Open Rotator Cuff Repair
1 other identifier
interventional
34
1 country
1
Brief Summary
This exploratory randomized controlled trial evaluated the association of interscalene brachial plexus block (ISB) with early postoperative wound-related symptom scores and perioperative biomarker responses in patients undergoing open rotator cuff repair. Participants were randomly allocated to receive either ultrasound-guided interscalene brachial plexus block or standardized general anaesthesia. The primary outcome was postoperative wound-related assessment using the Toronto Symptom Assessment System for Wounds (TSAS-W) on postoperative days 5 and 14. TSAS-W was used as an exploratory patient-reported wound symptom assessment tool. Secondary outcomes included perioperative serum cytokine and growth-factor concentrations (IL-1β, IL-2, TNF-α, EGF, PDGF, and TGF-β), platelet counts, postoperative pain scores, tramadol consumption within 48 hours, time to mobilisation, and postoperative nausea and vomiting. This study aimed to investigate whether interscalene brachial plexus block was associated with differences in perioperative biological responses and postoperative wound-related symptom scores compared with general anaesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2022
CompletedFirst Posted
Study publicly available on registry
August 12, 2022
CompletedStudy Start
First participant enrolled
February 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 17, 2024
CompletedJune 4, 2026
June 1, 2026
1.7 years
August 5, 2022
June 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Early postoperative wound-related symptom scores (TSAS-W)
Early postoperative wound-related symptoms assessed using the Toronto Symptom Assessment System for Wounds (TSAS-W), a patient-reported wound symptom assessment tool originally developed for chronic wound settings. TSAS-W was used as an exploratory patient-reported symptom assessment instrument rather than as an objective measure of wound healing.
Postoperative day 5 and day 14
Secondary Outcomes (6)
Perioperative cytokine and growth factor levels
Preoperative, 24 hours, and 48 hours postoperatively
Platelet count
Preoperative, 24 hours, and 48 hours postoperatively
Postoperative pain scores
Within 48 hours postoperatively
Postoperative tramadol consumption
Within 48 hours postoperatively
Time to mobilisation
Up to 48 hours after surgery
- +1 more secondary outcomes
Study Arms (2)
General Anesthesia Group
ACTIVE COMPARATORPatients undergoing open rotator cuff repair under standardized general anaesthesia. General anaesthesia was induced with propofol, fentanyl, and rocuronium, and maintained with sevoflurane. Additional intraoperative fentanyl was administered according to haemodynamic responses. Postoperative analgesia included paracetamol and rescue tramadol.
Interscalene Block Group
EXPERIMENTALPatients undergoing open rotator cuff repair with ultrasound-guided interscalene brachial plexus block using 20 mL of 0.25% bupivacaine. Surgery was performed under awake regional anaesthesia without routine sedation. Supplemental intravenous fentanyl boluses were permitted intraoperatively if clinically required according to predefined haemodynamic criteria. Postoperative analgesia included paracetamol and rescue tramadol.
Interventions
Standardized general anaesthesia using propofol, fentanyl, rocuronium, and sevoflurane in patients undergoing open rotator cuff repair. Additional intraoperative fentanyl was administered according to haemodynamic responses.
Ultrasound-guided interscalene brachial plexus block performed using 20 mL of 0.25% bupivacaine in patients undergoing open rotator cuff repair. Surgery was performed under awake regional anaesthesia without sedation or intraoperative opioids.
Eligibility Criteria
You may qualify if:
- Adult patients aged 18-65 years
- American Society of Anesthesiologists (ASA) physical status I-II
- Scheduled for elective open repair of a full-thickness rotator cuff tear
You may not qualify if:
- Pregnancy or lactation
- Known coagulopathy
- Chronic renal insufficiency
- Chronic hepatic insufficiency
- Significant uncontrolled cardiopulmonary disease
- Chronic opioid use
- Immunosuppressive therapy
- Diabetes mellitus or other uncontrolled metabolic disorders potentially affecting wound healing
- Chronic inflammatory disease
- Morbid obesity (body mass index ≥35 kg/m²)
- Allergy to amide local anaesthetics
- Infection at the injection site
- Emergency surgery
- Inability to complete postoperative assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Van Yüzüncü Yil University
Van, Bardakçı, 65100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arzu E Tekeli, MD
Yuzuncu Yil University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors, laboratory personnel, postoperative care staff, and the statistician were blinded to treatment allocation whenever feasible. Due to the nature of the intervention, participants and attending anaesthesiologists were not blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 5, 2022
First Posted
August 12, 2022
Study Start
February 3, 2023
Primary Completion
October 17, 2024
Study Completion
October 17, 2024
Last Updated
June 4, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data are not planned to be shared because the study involved a small exploratory sample and no formal data-sharing framework was established at the time of study conduct.